Fig. 3
From: Computational identification and evaluation of novel PD-L1 inhibitors for cancer immunotherapy

Crystallographic or experiment pose (Yellow) of CCL and its predicted structure pose (Blue) (Created with BIOVIA Discovery Studio Client 2021 version 21.1.0.20298).